VANDETANIB
|
凡德他尼
|
443913-73-3
|
LY-2157299
|
LY 2157299
|
700874-72-2
|
LY-2835219
|
LY2835219
|
1231930-82-7
|
4-iodo-1-(oxetan-3-yl)-1H-pyrazole
|
4-氧代-1-(氧杂环丁烷-3-基)-1H-吡唑
|
1314393-99-1
|
RAPAMYCIN
|
雷帕霉素
|
53123-88-9
|
PT-2385
|
CS-2108
|
1672665-49-4
|
TAS-120
|
FGFR抑制剂(FGFR-IN-1)
|
1448169-71-8
|
PQR-530
|
PQR530
|
1927857-61-1
|
INCB-057643
|
incb057643
|
1820889-23-3
|
SCH-772984
|
(R)-1-(2--2-氧(4-(4-(嘧啶-2-基)苯基)对二氮己环-1-基)乙基)-N-(3-(吡啶-4-基)-1H--5INDAZOL-基)吡咯烷-3-甲酰胺
|
942183-80-4
|
tert-butyl 6-chloronicotinate
|
6-氯烟酸叔丁酯
|
115309-57-4
|
GSK-923295
|
3-氯-N-{(1S)-2-[(N,N-二甲基甘氨酰)氨基]-1-[(4-{8-[(1S)-1-羟基乙基]咪唑并[1,2-A]吡啶-2-基}苯基)甲基]乙基}-4-[(1-甲基乙基)氧基]苯甲酰胺
|
1088965-37-0
|
PF-06840003
|
3-(5-氟-1H-吲哚-3-基)-2,5-吡咯烷二酮
|
198474-05-4
|
5-methoxy-1H-pyrazol-3-amine
|
5-METHOXY-1H-PYRAZOL-3-AMINE
|
41307-23-7
|
LY-2874455
|
LY2874455
|
1254473-64-7
|
TL-32711
|
比瑞那帕
|
1260251-31-7
|
SJB3-019A
|
SJB3-019A
|
2070015-29-9
|
PF-06747775
|
PF-06747775
|
1776112-90-3
|
Enasidenib mesylate
|
恩西地平甲磺酸盐
|
1650550-25-6
|
Furimazine
|
Furimazine
|
1374040-24-0
|
ODM-207
|
BET-IN-4
|
1801503-93-4
|
Enpatoran
|
化合物ENPATORAN
|
2101938-42-3
|
Acetic acid
|
BMS-309403 SODIUM
|
2802523-05-1
|
2-Azidobenzoic acid solution
|
2-叠氮苯甲酸 溶液
|
31162-13-7
|
5-methoxy-1H-pyrazol-3-amine hydrochloride
|
5-甲氧基-1H-吡唑-3-胺盐酸盐
|
110884-53-2
|
JNJ-38877618
|
JNJ-38877618
|
943540-74-7
|
RP-6306
|
RP-6306
|
2719793-90-3
|
4-bromo-3-fluorobenzenesulfonamide
|
4-溴-3-氟苯磺酰胺
|
263349-73-1
|
Boceprevir
|
波普瑞韦
|
394730-60-0
|
REGORAFENIB (BAY-73-4506)
|
瑞格非尼
|
755037-03-7
|
PKI-587
|
N-[4-[[4-(二甲基氨基)-1-哌啶基]羰基]苯基]-N'-[4-[4,6-二(4-吗啉基)-1,3,5-三嗪-2-基]苯基]脲
|
1197160-78-3
|
GSK-1120212
|
曲美替尼
|
871700-17-3
|
SB-939
|
(2E)-3-[2-丁基-1-[2-(二乙基氨基)乙基]-1H-苯并咪唑-5-基]-N-羟基丙烯酰胺
|
929016-96-6
|
GDC-0973
|
考比替尼
|
934660-93-2
|
IPI-145
|
IPI-145
|
1201438-56-3
|
6-bromo-2,3-dihydro-1H-pyrazolo[3,4-b]pyrazine
|
6-氯-1H-吡唑并[3,4-B]吡嗪
|
1260664-81-0
|
MG-132
|
MG132,蛋白酶体抑制剂
|
133407-82-6
|
LOXO-292
|
塞卡替尼
|
2152628-33-4
|
SAHA
|
伏立诺他
|
149647-78-9
|
LEE-011
|
瑞博西尼
|
1256963-02-6
|
JNJ-42756493
|
厄达替尼
|
1346242-81-6
|
GSK-2879552
|
GSK2879552
|
1401966-69-5
|
SU056
|
化合物SU056
|
2376580-08-2
|
5-isopropyl-1H-pyrazol-3-amine
|
5-异丙基-1H-吡唑-3-胺
|
56367-24-9
|
8-BOC-3,8-DIAZA-BICYCLO[3.2.1]OCTANE
|
8-BOC-3,8-二氮杂双环[3.2.1]辛烷
|
149771-44-8
|
GSK-2636771
|
GSK2636771
|
1372540-25-4
|
RVX208
|
RVX-208
|
1044870-39-4
|
methyl 3,5-difluoro-4-nitrobenzoate
|
3,5-二氟-4-硝基苯甲酸甲酯
|
1123172-87-1
|
3-(4-bromophenyl)pyrrolidine
|
3-(4-溴苯基)吡咯烷盐酸盐
|
1187931-39-0
|
GSK-343
|
GSK343
|
1346704-33-3
|
TAK-632
|
TAK-632
|
1228591-30-7
|
3-(6-oxo-1,6-dihydropyridazin-3-yl)benzonitrile
|
3-(6-羰基-1,6-二氢-3-哒嗪基)苯氰
|
52240-08-1
|
AZD-5069
|
AZD5069
|
878385-84-3
|
GDC-0917
|
1446182-94-0
|
1446182-94-0
|
4-chloro-5-(trifluoromethyl)pyrimidin-2-amine
|
4-氯-5-(三氟甲基)嘧啶-2-胺
|
1201657-24-0
|
H3B-6545
|
H3B-6545
|
2052130-80-8
|
LBH-589
|
帕比司他
|
404950-80-7
|
tert-butyl 6-hydrazinylnicotinate
|
6-肼基烟酸叔丁酯
|
163213-19-2
|
MLN-2238
|
艾沙佐米
|
1072833-77-2
|
c-Fms-IN-3
|
4-氰基-N-[4-(4-甲基-1-哌嗪基)-2-(4-甲基-1-哌啶基)苯基]-1H-吡咯-2-甲酰胺
|
885704-21-2
|
GSK-2606414
|
GSK2606414
|
1337531-36-8
|
2-methyl-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propan-2-ol
|
1-(2-羟基-2-甲基-丙基)吡唑-4-基]硼酸哪醇酯
|
1082503-77-2
|
methyl 4-methyl-3-(trifluoromethyl)benzoate
|
4-甲基-3-三氟甲基苯甲酸甲酯
|
116419-94-4
|
JNJ-26483327
|
17-溴-1,8,9,10,11,12,13,14-八氢-20-甲氧基-13-甲基-4,6-乙烯桥嘧啶并[4,5-B][6,1,12]苯并氧杂二氮杂环十五碳七烯
|
807640-87-5
|
GKT-137831
|
2-(2-氯苯基)-4-[3-(二甲基氨基)苯基]-5-甲基-1H-吡唑并[4,3-C]吡啶-3,6(2H,5H)-二酮
|
1218942-37-0
|
IDF-11774
|
化合物IDF-11774
|
1429054-28-3
|
1-Azakenpaullone
|
1-氮杂坎帕罗酮
|
676596-65-9
|
AS-1763
|
AS1763
|
2227211-00-7
|
7-bromo-2-chloroquinazoline
|
7-溴-2-氯喹唑啉
|
953039-66-2
|
PLX-4720
|
N-[3-[(5-氯-1H-吡咯并[2,3-B]吡啶-3-基)羰基]-2,4-二氟苯基]-1-丙磺酰胺
|
918505-84-7
|
GSK-126
|
GSK126
|
1346574-57-9
|
TAK-441
|
TAK-441
|
1186231-83-3
|
LGK-974
|
2',3-二甲基-N-[5-(2-吡嗪基)-2-吡啶基]-[2,4'-联吡啶]-5-乙酰胺
|
1243244-14-5
|
LY-3009120
|
LY-3009120
|
1454682-72-4
|
TD139
|
TD139
|
1450824-22-2
|
MTX-211
|
MTX-211
|
1952236-05-3
|
6-chloro-3-iodo-1H-pyrazolo[3,4-b]pyrazine
|
6-氯-3-碘-1H-吡唑并[3,4-B]吡嗪
|
1935196-58-9
|
6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one
|
6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one
|
1703794-32-4
|
6-chloro-3-iodo-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-b]pyrazine
|
6-Chloro-3-Iodo-1-Tetrahydropyran-2-Yl-Pyrazolo[3,4-B]Pyrazine
|
2215028-64-9
|
Dot1L-IN-4
|
QQN05022
|
2565705-02-2
|
JDQ-443
|
JDQ-443
|
2653994-08-0
|
(4,6-dimethylpyridin-3-yl)methanamine
|
(4,6-二甲基吡啶-3-基)甲胺
|
98489-36-2
|
PLX-4032
|
N-[2,4-二氟-3-[[5-(3-吡啶基)-1H-吡咯并[2,3-B]吡啶-3-基]羰基]苯基]-2-丙磺酰胺
|
918505-61-0
|
R-1479
|
4'-叠氮基胞嘧啶核苷
|
478182-28-4
|
5-bromo-1H-pyrazol-3-amine
|
3-溴-1H-吡唑-5-胺
|
950739-21-6
|
SCH-900776
|
SCH-900776
|
891494-64-7
|
RO-5126766
|
RO5126766(CH5126766)
|
946128-88-7
|
RMC-4550
|
RMC-4550
|
2172651-73-7
|
SR-4835
|
SR-4835
|
2387704-62-1
|
LAPATINIB
|
拉帕替尼
|
231277-92-2
|
Baxdrostat
|
BAXDROSTAT
|
1428652-17-8
|
JBJ-09-063
|
2-(5-氟-2-羟基苯基)-2-(6-(4-(1-甲基哌啶-4-基)苯基)-1-氧代异吲哚啉-2-基)-N-(噻唑-2-基)乙酰胺
|
2820336-67-0
|
SORAFENIB
|
索拉非尼
|
284461-73-0
|
INK-128
|
3-(2-氨基-5-苯并恶唑基)-1-(1-甲基乙基)-1H-吡唑并[3,4-D]嘧啶-4-胺
|
1224844-38-5
|
LY-2801653
|
梅沙替尼
|
1206799-15-6
|
5-(oxetan-3-yl)-1H-pyrazol-3-amine
|
5-Oxetan-3-yl-1H-pyrazol-3-ylaMine
|
1425932-06-4
|
1-(3-amino-1H-pyrazol-5-yl)ethanone hydrochloride
|
Ethanone, 1-(5-aMino-1H-pyrazol-3-yl)-, hydrochloride
|
1373267-26-5
|
GDC-0084
|
GDC-0084
|
1382979-44-3
|
EED-226
|
EED226
|
2083627-02-3
|
Benzoic acid
|
|
2519537-70-1
|